Literature DB >> 16410448

Host factors that impact the biodistribution and persistence of multipotent adult progenitor cells.

Jakub Tolar1, Matthew J O'shaughnessy, Angela Panoskaltsis-Mortari, Ron T McElmurry, Scott Bell, Megan Riddle, R Scott McIvor, Stephen R Yant, Mark A Kay, Diane Krause, Catherine M Verfaillie, Bruce R Blazar.   

Abstract

Multipotent adult progenitor cells (MAPCs) are marrow-derived pluripotent stem cells with a broad differentiation potential. We sought to identify factors that affect adoptively transferred MAPCs. In vitro, MAPCs expressed low levels of major histocompatibility complex (MHC) antigens, failed to stimulate CD4(+) and CD8(+) T-cell alloresponses, and were targets of NK cytolysis. To study in vivo biodistribution, we labeled MAPCs with luciferase for sequential quantification of bioluminescence and DsRed2 for immunohistochemical analysis. C57BL /6 MAPCs were infused intravenously into C57BL /6, Rag-2(-/-) (T- and B-cell-deficient), and Rag-2(-/-)/IL-2Rgamma(c)(-/-) (T-, B-, and NK-cell-deficient) mice. In C57BL /6 mice, MAPCs were transiently detected only in the chest compared with long-term persistence in T- and B-cell-deficient mice. NK depletion reduced MAPC elimination. Because the lungs were the major uptake site after intravenous injection, intra-arterial injections were tested and found to result in more widespread biodistribution. Widespread MAPC biodistribution and long-term persistence were seen in irradiated recipients given allogeneic marrow and MAPCs; such MAPCs expressed MHC class I antigens in tissues. Our data indicate that the biodistribution and persistence of reporter gene-labeled MAPCs are maximized after intra-arterial delivery or host irradiation and that T cells, B cells, and NK cells contribute to in vivo MAPC rejection.

Entities:  

Mesh:

Year:  2006        PMID: 16410448      PMCID: PMC1895284          DOI: 10.1182/blood-2005-08-3289

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  29 in total

1.  Nonmyeloablative immunosuppressive regimen prolongs In vivo persistence of gene-modified autologous T cells in a nonhuman primate model.

Authors:  C Berger; M L Huang; M Gough; P D Greenberg; S R Riddell; H P Kiem
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

2.  Characterization of multipotent adult progenitor cells, a subpopulation of mesenchymal stem cells.

Authors:  M Reyes; C M Verfaillie
Journal:  Ann N Y Acad Sci       Date:  2001-06       Impact factor: 5.691

3.  Rapidly maturing variants of the Discosoma red fluorescent protein (DsRed).

Authors:  Brooke J Bevis; Benjamin S Glick
Journal:  Nat Biotechnol       Date:  2002-01       Impact factor: 54.908

4.  Homeostatic expansion occurs independently of costimulatory signals.

Authors:  M Prlic; B R Blazar; A Khoruts; T Zell; S C Jameson
Journal:  J Immunol       Date:  2001-11-15       Impact factor: 5.422

5.  Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell.

Authors:  D S Krause; N D Theise; M I Collector; O Henegariu; S Hwang; R Gardner; S Neutzel; S J Sharkis
Journal:  Cell       Date:  2001-05-04       Impact factor: 41.582

6.  Real-time in vivo imaging of stem cells following transgenesis by transposition.

Authors:  Jakub Tolar; Mark Osborn; Scott Bell; Ron McElmurry; Lily Xia; Megan Riddle; Angela Panoskaltsis-Mortari; Yuehua Jiang; R Scott McIvor; Christopher H Contag; Stephen R Yant; Mark A Kay; Catherine M Verfaillie; Bruce R Blazar
Journal:  Mol Ther       Date:  2005-07       Impact factor: 11.454

7.  Origin of endothelial progenitors in human postnatal bone marrow.

Authors:  Morayma Reyes; Arkadiusz Dudek; Balkrishna Jahagirdar; Lisa Koodie; Paul H Marker; Catherine M Verfaillie
Journal:  J Clin Invest       Date:  2002-02       Impact factor: 14.808

8.  Human bone marrow stem cells exhibit neural phenotypes and ameliorate neurological deficits after grafting into the ischemic brain of rats.

Authors:  Li-Ru Zhao; Wei-Ming Duan; Morayma Reyes; C Dirk Keene; Catherine M Verfaillie; Walter C Low
Journal:  Exp Neurol       Date:  2002-03       Impact factor: 5.330

9.  Multipotent adult progenitor cells from bone marrow differentiate into functional hepatocyte-like cells.

Authors:  Robert E Schwartz; Morayma Reyes; Lisa Koodie; Yuehua Jiang; Mark Blackstad; Troy Lund; Todd Lenvik; Sandra Johnson; Wei-Shou Hu; Catherine M Verfaillie
Journal:  J Clin Invest       Date:  2002-05       Impact factor: 14.808

10.  Distinct phases in recovery of reconstituted innate cellular-mediated immunity after murine syngeneic bone marrow transplantation.

Authors:  Jeffery J Auletta; Jennifer L Devecchio; James L M Ferrara; Frederick P Heinzel
Journal:  Biol Blood Marrow Transplant       Date:  2004-12       Impact factor: 5.742

View more
  26 in total

Review 1.  Emerging therapeutic approaches for multipotent mesenchymal stromal cells.

Authors:  Paolo F Caimi; Jane Reese; Zhenghong Lee; Hillard M Lazarus
Journal:  Curr Opin Hematol       Date:  2010-11       Impact factor: 3.284

Review 2.  Stem cells and cell therapies in lung biology and lung diseases.

Authors:  Daniel J Weiss; Jay K Kolls; Luis A Ortiz; Angela Panoskaltsis-Mortari; Darwin J Prockop
Journal:  Proc Am Thorac Soc       Date:  2008-07-15

3.  Transient proteolytic modification of mesenchymal stromal cells increases lung clearance rate and targeting to injured tissue.

Authors:  Erja Kerkelä; Tanja Hakkarainen; Tuomas Mäkelä; Mari Raki; Oleg Kambur; Lotta Kilpinen; Janne Nikkilä; Siri Lehtonen; Ilja Ritamo; Roni Pernu; Mika Pietilä; Reijo Takalo; Tatu Juvonen; Kim Bergström; Eija Kalso; Leena Valmu; Saara Laitinen; Petri Lehenkari; Johanna Nystedt
Journal:  Stem Cells Transl Med       Date:  2013-06-03       Impact factor: 6.940

4.  Angiogenesis induced by autologous whole bone marrow stem cells transplantation.

Authors:  Kyung-Bok Lee; Ae-Kyung Kim; Mi-Jung Kim; Young-Soo Do; Sung-Wook Shin; Jong-Sung Kim; Chan-Jeong Park; Kyung-Sun Kang; Byung-Soo Kim; Jin-Hyun Joh; Won-Il Oh; Hye-Kyung Hong; Dong-Ik Kim
Journal:  Int J Stem Cells       Date:  2008-11       Impact factor: 2.500

5.  Stem cells and cell therapies in lung biology and lung diseases.

Authors:  Daniel J Weiss; Ivan Bertoncello; Zea Borok; Carla Kim; Angela Panoskaltsis-Mortari; Susan Reynolds; Mauricio Rojas; Barry Stripp; David Warburton; Darwin J Prockop
Journal:  Proc Am Thorac Soc       Date:  2011-06

6.  Major histocompatibility complex-I expression on embryonic stem cell-derived vascular progenitor cells is critical for syngeneic transplant survival.

Authors:  Mingchao Ma; Shunli Ding; Andreas Lundqvist; Hong San; Fang Fang; Mikhail Konoplyannikov; Colin Berry; Leilani E Beltran; Guibin Chen; Jason C Kovacic; Manfred Boehm
Journal:  Stem Cells       Date:  2010-09       Impact factor: 6.277

7.  An engineered biomarker system to monitor and modulate immune clearance of cell therapies.

Authors:  Amy Singleton; Danika Khong; Ling-Yee Chin; Shilpaa Mukundan; Matthew Li; Biju Parekkadan
Journal:  Cytotherapy       Date:  2017-09-13       Impact factor: 5.414

Review 8.  Regenerative stromal cell therapy in allogeneic hematopoietic stem cell transplantation: current impact and future directions.

Authors:  Jeffery J Auletta; Kenneth R Cooke; Luis A Solchaga; Robert J Deans; Wouter van't Hof
Journal:  Biol Blood Marrow Transplant       Date:  2009-12-16       Impact factor: 5.742

Review 9.  Cell therapies for traumatic brain injury.

Authors:  Matthew T Harting; James E Baumgartner; Laura L Worth; Linda Ewing-Cobbs; Adrian P Gee; Mary-Clare Day; Charles S Cox
Journal:  Neurosurg Focus       Date:  2008       Impact factor: 4.047

10.  Multipotent adult progenitor cells can suppress graft-versus-host disease via prostaglandin E2 synthesis and only if localized to sites of allopriming.

Authors:  Steven L Highfill; Ryan M Kelly; Matthew J O'Shaughnessy; Qing Zhou; Lily Xia; Angela Panoskaltsis-Mortari; Patricia A Taylor; Jakub Tolar; Bruce R Blazar
Journal:  Blood       Date:  2009-05-20       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.